-
NSE
1,760.00 1,878.00(%) -
M & M
2,838.00 2,812.60(%) -
Kotak Mah. Bank
435.25 452.98(%) -
ITC
264.00 254.75(%) -
Swiggy
244.60 460.00(%) -
SS Retail
728.80 888.00(%) -
Orient Cables
363.00 363.00(%) -
Hind.Aeronautics
4,834.80 5,149.90(%) -
Apollo Hospitals
7,803.15 6,680.00(%) -
Meesho
244.00 254.65(%) -
Trent
2,914.55 3,399.75(%) -
Kanohar Elect.
917.00 672.05(%) -
Bharti Airtel
1,809.00 2,174.70(%) -
B H E L
453.80 453.80(%) -
ICICI Bank
1,343.40 1,479.90(%) -
PB Fintech.
1,041.90 1,963.00(%) -
HDFC Bank
714.40 1,020.35(%) -
Reliance Industries
1,219.00 1,611.20(%) -
One Mobikwik
242.10 296.75(%) -
Optiemus Infra.
925.70 925.70(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Torrent Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
- Torrent
- BSE Code : 3616.0
- ISIN : INE685A01028
-
Today’s Low
4,702.50 -
Today’s High
4,788.30
-
Open
4,763.50 -
Perv Close
4,772.00 -
52W Low
3,480.60 -
52W High
5,250.00
Key Indicators
-
P/E(TTM)
88.61
-
Mar.Cap (₹Cr.)
181,511.54
-
Div & Yield %
0.71
-
Book Value(₹)
222.76
-
Debt-Equity Ratio
0.00
-
AGM Date
06-Oct-2026
-
EPS
53.92
-
P/E Ratio
88.61
Financials Ratios
-
Debt-Equity Ratio
0.72
-
Mar.Cap (₹Cr.)
181,511.54
-
RONW (%)
25.38
-
ROCE (%)
23.21
Score Board
-
Equity (₹ in Cr.)
190.18
-
BV (₹)
222.80
-
Sales( ₹ in Cr.)
10,713.14
-
NP (in Cr.)
2,212.52
-
NP Var(%)
17.0
-
Div%
760.0
-
CPS (₹)
78.20
-
EPS (₹)
58.20
-
Traded Value (₹ in Lakhs)
181,739.76
-
52 Week High
5,250.00
-
52 Week Low
3,480.60
-
Price BSE
4778.0
-
Price NSE
4,772.00
-
Market Capital( in Cr.)
181,739.76
-
P/C Ratio
61.10
-
P/E Ratio
82.10
-
Price Vs.BV
58.20
-
06-Oct-2026( 08:16)
Corporate News - Torre... - <p>Torrent Pharmaceuticals Ltd...
-
28-Sep-2026( 12:24)
Corporate News - Torre... - <p>Torrent Pharmaceuticals Ltd...
-
28-Sep-2026( 12:20)
Corporate News - Torre... - <p>Torrent Pharmaceuticals Lim...
-
07-Aug-2026( 01:35)
Hot Pursuit - Torre... - <p>Torrent Pharmaceuticals Ltd...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 10,713.14 | 9,683.43 | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10,713.14 | 9,683.43 | 8,532.90 | 7,695.20 | 6,742.32 | 6,450.57 |
| Other Income | 17.92 | 31.50 | 91.36 | 81.88 | 204.17 | 118.34 |
| Stock Adjustments | 22.28 | 9.04 | 68.61 | -128.44 | 18.34 | 150.14 |
| Total Income | 10,753.34 | 9,723.97 | 8,692.87 | 7,648.64 | 6,964.83 | 6,719.05 |
| EXPENDITURE : | ||||||
| Raw Materials | 2,334.64 | 2,249.84 | 2,200.39 | 2,010.98 | 1,925.84 | 1,819.81 |
| Power and Fuel Cost | 138.74 | 134.25 | 143.43 | 153.21 | 140.00 | 122.04 |
| Employee Cost | 1,879.40 | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 | 1,097.12 |
| Other Manufacturing Expenses | 227.68 | 189.02 | 173.82 | 143.39 | 141.56 | 136.19 |
| Selling and Administration Expenses | 1,558.61 | 1,397.82 | 1,254.38 | 1,138.57 | 954.66 | 851.08 |
| Miscellaneous Expenses | 613.16 | 533.53 | 489.52 | 404.23 | 399.91 | 382.74 |
| Employee Benefit Expenses | 1,879.40 | 1,636.45 | 1,450.67 | 1,251.22 | 1,097.93 | 1,097.12 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 6,752.23 | 6,140.91 | 5,712.21 | 5,101.60 | 4,659.90 | 4,408.98 |
| Operating Profit | 4,001.11 | 3,583.06 | 2,980.66 | 2,547.04 | 2,304.93 | 2,310.07 |
| Interest | 340.96 | 213.40 | 303.04 | 297.68 | 236.29 | 334.12 |
| Gross Profit | 3,660.15 | 3,369.66 | 2,677.62 | 2,249.36 | 2,068.64 | 1,975.95 |
| Depreciation | 763.54 | 759.48 | 761.05 | 672.34 | 602.43 | 609.84 |
| Profit Before Tax | 2,896.61 | 2,610.18 | 1,916.57 | 1,577.02 | 1,466.21 | 1,366.11 |
| Current Tax | 720.20 | 540.56 | 321.67 | 274.20 | 253.27 | 247.77 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -15.18 | 181.56 | 237.82 | 251.43 | 221.49 | -19.51 |
| Reported Net Profit | 2,191.59 | 1,888.06 | 1,357.08 | 1,051.39 | 991.45 | 1,137.85 |
| Extraordinary Items | -20.93 | -4.20 | 14.88 | 27.97 | 6.86 | 12.75 |
| Adjusted Net Profit | 2,212.52 | 1,892.26 | 1,342.20 | 1,023.42 | 984.59 | 1,125.10 |
| Adjustment below Net Profit | -4.60 | -27.14 | 0.44 | -7.07 | -1.55 | 7.21 |
| P & L Balance brought forward | 4,514.33 | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 | 2,093.30 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 1,184.53 | 1,082.98 | 1,015.34 | 863.03 | 676.89 | 338.45 |
| P & L Balance carried down | 5,516.79 | 4,514.33 | 3,736.39 | 3,394.21 | 3,212.92 | 2,899.91 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 760.00 | 640.00 | 560.00 | 440.00 | 960.00 | 700.00 |
| Dividend Per Share(Rs) | 38.00 | 32.00 | 28.00 | 22.00 | 48.00 | 35.00 |
| Earnings Per Share-Unit Curr | 64.75 | 55.78 | 40.10 | 31.06 | 58.58 | 67.23 |
| Earnings Per Share(Adj)-Unit Curr | 64.75 | 55.78 | 40.10 | 31.06 | 29.29 | 33.62 |
| Book Value | 249.72 | 224.32 | 201.76 | 190.75 | 374.94 | 356.30 |
| Book Value(Adj)-Unit Curr | 249.72 | 224.32 | 201.76 | 190.75 | 187.47 | 178.15 |
